Delivery Order SPE2DP25D0003-SPE2DP25F4411
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $1,336,273.60, is for the delivery of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, by the Defense Logistics Agency (DLA) for the delivery of influenza virus vaccines. The contract has a ceiling value of $23,926.32 and an ultimate completion date of April 18, 2025. The contract is a delivery order, with a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) vehicle held by Sanofi Pasteur Inc. with various federal agencies,...
- This is a $6,025,705.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of influenza virus vaccines. The contract has an ultimate completion date of September 26, 2025 and does not utilize any set-aside designations. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
- This contract award is for the delivery of Influenza Virus Vaccine to the U.S. government. The contract was awarded to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccine production and medical supplies. The contract has a ceiling value of $3,472.00 and a performance period through September 26, 2025. It is a firm fixed-price Delivery Order contract awarded by the Medical Supply Chain, which is an alternate name for the Defense federal agency. The...
- This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of vaccines and pharmaceuticals, for the production and delivery of influenza virus vaccines. The award, valued at $559,592.55, was made by the Defense Logistics Agency (DLA), a defense agency, on a firm fixed price basis without any set-aside designation. The contract has an ultimate completion date of March 31, 2025. Sanofi Pasteur Inc. is an experienced government contractor, holding several...
- This federal contract award to Sanofi Pasteur Inc. is for the delivery of influenza virus vaccines. The contract, valued at $1,032.12, was awarded by the Medical Supply Chain unit of the Defense Department's Defense Logistics Agency. It is a firm fixed price purchase order without any set-aside designation. Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, is the prime contractor. The contract utilizes Sanofi Pasteur's production and distribution capabilities to provide vaccines in...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The contract, valued at $3,893,798.40, is for the delivery of influenza virus vaccines. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies. The $74,400.00 firm fixed price delivery order contract is for the provision of influenza virus vaccines. The contract does not have a set-aside designation. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies, including the Centers...
- Sanofi Pasteur Inc., a foreign-owned for-profit manufacturer, has been awarded a firm fixed price Delivery Order contract by the Defense Logistics Agency Troop Support Medical for $2,650.81 to provide influenza virus vaccines. The contract has a completion date of March 29, 2024. This award is not associated with a set-aside program. Sanofi Pasteur Inc. is a major supplier of vaccines and pharmaceuticals to various U.S. government agencies, including the Department of Veterans Affairs, Centers...
- This federal contract award was made by the Defense Logistics Agency Troop Support Medical to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of goods. The contract is for the provision of influenza virus vaccines, with a firm fixed price of $140,075.46 and a completion date of October 25, 2019. The contract has no set-aside designation. Sanofi Pasteur Inc. is a major supplier of vaccines, pharmaceuticals, and medical supplies to various U.S. government agencies, including the...
- SPE2DP25D0003Indefinite Delivery Contract
- SPE2DP25D0003-SPE2DP25F4411Delivery Order
This is a federal contract award to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies, for the provision of influenza virus vaccines. The contract has a ceiling value of $983,915.20 and is a firm fixed price delivery order, with an ultimate completion date of September 26, 2025. The contract is awarded by the Defense Logistics Agency, a component of the Department of Defense, and is not set aside for any specific business category. Sanofi Pasteur Inc. is a major global supplier of vaccines and medical countermeasures to various U.S. federal government agencies, including the Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Health and Human Services. The company holds multiple significant Indefinite Delivery Contracts (IDVs) across these agencies for the procurement of diverse vaccine types, such as influenza, measles, mumps, rubella, hepatitis, pneumococcal, and meningococcal vaccines, to support national immunization programs and emergency preparedness efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $983.9k | 3/5/25 |